CRISPR Therapeutics AG (0VRQ)
LSE
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Dr. Naimish PatelChief Medical Officer | -3.79k | 210.58k | Derivative Exercise and Sale | 55.62 | 19.36k | - |
| 2026-05-28 | Dr. Naimish PatelChief Medical Officer | 6.21k | 0.00 | Derivative Exercise and Retained Stock | - | 19.36k | 47.28% |
| 2026-03-20 | Mr. James R. KasingerGeneral Counsel & Secretary | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 94.31k | 3.36% |
| 2026-03-20 | Mr. James R. KasingerGeneral Counsel & Secretary | -3.18k | 148.85k | Derivative Exercise and Sale | 46.78 | 94.31k | - |
| 2026-03-20 | Dr. Samarth KulkarniCEO & Chairman | 9.67k | 0.00 | Derivative Exercise and Retained Stock | - | 255.50k | 3.93% |
| 2026-03-20 | Dr. Samarth KulkarniCEO & Chairman | -10.02k | 468.74k | Derivative Exercise and Sale | 46.78 | 255.50k | - |
| 2026-03-20 | Dr. Raju Yashaswi PrasadCFO | 2.54k | 0.00 | Derivative Exercise and Retained Stock | - | 15.57k | 19.52% |
| 2026-03-20 | Dr. Raju Yashaswi PrasadCFO | -3.71k | 173.46k | Derivative Exercise and Sale | 46.78 | 15.57k | - |
| 2026-03-14 | Dr. Naimish PatelChief Medical Officer | -3.15k | 152.02k | Derivative Exercise and Sale | 48.26 | 13.14k | - |
| 2026-03-14 | Dr. Naimish PatelChief Medical Officer | 4.98k | 0.00 | Derivative Exercise and Retained Stock | - | 13.14k | 60.91% |
| 2026-03-14 | Dr. Raju Yashaswi PrasadCFO | 6.26k | 0.00 | Derivative Exercise and Retained Stock | - | 13.02k | 92.45% |
| 2026-03-14 | Dr. Raju Yashaswi PrasadCFO | -10.62k | 476.28k | Derivative Exercise and Sale | 48.26 | 13.02k | - |
| 2026-03-14 | Mr. James R. KasingerGeneral Counsel & Secretary | 3.43k | 0.00 | Derivative Exercise and Retained Stock | - | 91.24k | 3.90% |
| 2026-03-14 | Mr. James R. KasingerGeneral Counsel & Secretary | -3.45k | 166.50k | Derivative Exercise and Sale | 48.26 | 91.24k | - |
| 2026-03-14 | Dr. Samarth KulkarniCEO & Chairman | 10.28k | 0.00 | Derivative Exercise and Retained Stock | - | 245.83k | 4.36% |
| 2026-03-14 | Dr. Samarth KulkarniCEO & Chairman | -10.35k | 499.44k | Derivative Exercise and Sale | 48.26 | 245.83k | - |
| 2026-03-10 | Mr. James R. KasingerGeneral Counsel & Secretary | 2.70k | 0.00 | Derivative Exercise and Retained Stock | - | 87.82k | 3.17% |
| 2026-03-10 | Mr. James R. KasingerGeneral Counsel & Secretary | -2.80k | 147.84k | Derivative Exercise and Sale | 52.80 | 87.82k | - |
| 2026-03-10 | Dr. Samarth KulkarniCEO & Chairman | 9.45k | 0.00 | Derivative Exercise and Retained Stock | - | 235.56k | 4.18% |
| 2026-03-10 | Dr. Samarth KulkarniCEO & Chairman | -9.80k | 517.33k | Derivative Exercise and Sale | 52.80 | 235.56k | - |
| 2026-02-18 | Dr. Samarth KulkarniCEO & Chairman | 6.28k | 0.00 | Derivative Exercise and Retained Stock | - | 226.11k | 2.86% |
| 2026-02-18 | Dr. Samarth KulkarniCEO & Chairman | -6.97k | 366.32k | Derivative Exercise and Sale | 52.58 | 226.11k | - |
| 2026-02-18 | Mr. James R. KasingerGeneral Counsel & Secretary | 1.71k | 0.00 | Derivative Exercise and Retained Stock | - | 85.12k | 2.05% |
| 2026-02-18 | Mr. James R. KasingerGeneral Counsel & Secretary | -2.11k | 111.05k | Derivative Exercise and Sale | 52.58 | 85.12k | - |
| 2025-04-03 | Dr. Naimish PatelChief Medical Officer | 1.51k | 49.70k | 買い | 32.96 | 1.51k | - |
| 2026-01-22 | Dr. Raju Yashaswi PrasadCFO | -34.97k | 525.98k | Derivative Exercise and Sale | 45.15 - 60.19 | 6.77k | - |
| 2026-01-20 | Dr. Samarth KulkarniCEO & Chairman | -90.00k | 5.17M | Automatic Disposition | 51.61 - 60.23 | 219.82k | -29.05% |
| 2026-01-06 | Dr. Raju Yashaswi PrasadCFO | -29.70k | 451.01k | Derivative Exercise and Sale | 44.31 - 60.21 | 6.77k | - |
| 2025-12-22 | Dr. Raju Yashaswi PrasadCFO | -10.00k | 559.55k | Automatic Disposition | 55.10 - 56.89 | 6.77k | -59.64% |
| 2025-12-18 | Dr. Samarth KulkarniCEO & Chairman | -30.00k | 0.00 | Other Disposition | - | 309.82k | -8.83% |
| 2025-10-16 | Dr. Samarth KulkarniCEO & Chairman | 49.11k | 0.00 | Derivative Exercise and Retained Stock | - | 339.86k | 16.89% |
| 2025-10-16 | Dr. Samarth KulkarniCEO & Chairman | -50.90k | 3.46M | Derivative Exercise and Sale | 67.91 | 339.86k | - |
| 2025-10-13 | Mr. James R. KasingerGeneral Counsel & Secretary | 1.04k | 0.00 | Derivative Exercise and Retained Stock | - | 83.40k | 1.26% |
| 2025-10-13 | Mr. James R. KasingerGeneral Counsel & Secretary | -1.08k | 71.66k | Derivative Exercise and Sale | 66.60 | 83.40k | - |
| 2025-10-13 | Dr. Samarth KulkarniCEO & Chairman | 4.09k | 0.00 | Derivative Exercise and Retained Stock | - | 290.76k | 1.43% |
| 2025-10-13 | Dr. Samarth KulkarniCEO & Chairman | -4.24k | 282.52k | Derivative Exercise and Sale | 66.60 | 290.76k | - |
| 2025-09-17 | Dr. Samarth KulkarniCEO & Chairman | -6.00k | 0.00 | Other Disposition | - | 286.63k | -2.05% |
| 2025-08-16 | Dr. Samarth KulkarniCEO & Chairman | 11.92k | 0.00 | Derivative Exercise and Retained Stock | - | 292.63k | 4.25% |
| 2025-08-16 | Dr. Samarth KulkarniCEO & Chairman | -13.08k | 760.66k | Derivative Exercise and Sale | 58.15 | 292.63k | - |
| 2025-08-06 | Dr. Douglas A. TrecoLead Independent Director | 20.00k | 1.14M | 買い | 57.03 | 22.00k | 1,000.00% |
| 2025-07-16 | SR One Capital Management, LP法人 | 989.81k | 51.50M | 買い | 52.03 | 2.04M | 94.36% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。